Target intelligence / Profile preview

Partner and localizer of BRCA2 (PALB2)

Target
PALB2
Molecular classification
Tumor suppressor, DNA repair protein, Scaffold protein, Other
01

Overview

Partner and localizer of BRCA2 (PALB2) is a tumor suppressor protein essential for homologous recombination-mediated repair of DNA double-strand breaks. It acts as a scaffold, recruiting and stabilizing BRCA2 and RAD51 at sites of DNA damage, and directly interacts with BRCA1 to promote the assembly of DNA repair complexes. PALB2 helps to maintain genomic integrity, prevent accumulation of DNA damage, and suppress tumorigenesis. Inherited monoallelic mutations confer a significantly increased risk of breast, pancreatic, and ovarian cancers, whereas biallelic mutations cause Fanconi anemia subtype N, characterized by early-onset cancer predisposition and hematologic disorders. PALB2-deficient cancers may be sensitive to synthetic lethal approaches such as PARP inhibition[1][3][4][5][6][7].

Other names
FANCNFanconi anemia, complementation group NPNCA3FLJ21816BROVCA5partner and localizer of BRCA2mutant partner and localizer of BRCA2
02

Mechanism of action

Synthetic lethality in homologous recombination-deficient cancers by PARP inhibition

03

Biological functions

DNA double-strand break repairHomologous recombinationGenome stability maintenanceTumor suppressionChromatin association
04

Disease associations

Cancer (notably breast cancer, pancreatic cancer, ovarian cancer)Fanconi anemia (subtype N)Other malignancies linked to hereditary cancer predisposition
05

Safety considerations

Hematological toxicity in Fanconi anemia when biallelic mutations are presentGenomic instabilityLimited therapeutic window due to DNA repair defects
06

Interacting drugs

PARP inhibitors (e.g., olaparib, talazoparib)
07

Biomarkers

Germline or somatic PALB2 mutations (for cancer risk, PARP inhibitor response)

Beyond the preview

Go deeper on Partner and localizer of BRCA2 (PALB2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Partner and localizer of BRCA2 (PALB2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call